Report of Foreign Issuer (6-k)
October 11 2018 - 9:36AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
W
ashington,
D.C.
20549
FORM
6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13a-16 or 15d-16
of the
Securities Exchange Act of 1934
For
the month of October 2018
Commission
File Number: 001-37643
KITOV
PHARMA
LTD.
(Translation
of registrant's name into English)
One
Azrieli Center, Round Tower,
Tel
Aviv 6701101, Israel
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
On
October 11, 2018, Kitov Pharma
Ltd. (the “Company” or the “Registrant”) issued a Press Release:
“
Kitov Appoints Gil Efron as Deputy Chief Executive Officer and Chief Financial Officer”.
A copy of this press
release is furnished herewith as Exhibit 99.1.
This
Form 6-K, including the entire Exhibit 99.1 attached hereto, are all hereby incorporated by reference into each of the Registrant’s
Registration Statements on Form F-3 filed with the Securities and Exchange Commission on December 12, 2016 (Registration file
numbers 333-207117, 333-211477 and 333-215037), the Registrant’s Registration Statement on Form S-8 filed with the Securities
and Exchange Commission on May 20, 2016 (Registration file number 333-211478), the Registrant’s Registration Statement
on Form S-8 filed with the Securities and Exchange Commission on June 6, 2017 (Registration file number 333-218538), and
the Registrant’s Registration Statement on Form F-3 filed with the Securities and Exchange Commission on July 16, 2018 (Registration
file number 333-226195).
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
KITOV PHARMA LTD.
|
|
|
October 11, 2018
|
By:
|
/s/
Simcha Rock
|
|
|
Simcha Rock
|
|
|
CFO and Director
|
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Kitov Pharma (NASDAQ:KTOV)
Historical Stock Chart
From Apr 2023 to Apr 2024